Pfizer is close to a deal with the Trump administration to deliver 100 million more vaccine doses

As the U.S. government faces a massive shortage in coronavirus vaccines, it nears a new deal with Pfizer that would grant the pharmaceutical company greater access to supplies needed to develop a dose.